Noradrenergic regulation of glial activation: Molecular mechanisms and therapeutic implications

Medicine and Dentistry

• Noradrenalin 100%
• Diseases 42%
• Neuroprotective Agent 28%
• Transcription Factors 28%
• Neuropathology 14%
• Alzheimer's Disease 14%
• Gene Expression 14%
• In Vitro 14%
• Glial Cell Line Derived Neurotrophic Factor 14%
• Parkinson's Disease 14%
• Multiple Sclerosis 14%
• Receptor 14%
• Down Syndrome 14%
• Brain Derived Neurotrophic Factor 14%
• Posttraumatic Stress Disorder 14%
• Neurotransmitter 14%

Neuroscience

• Norepinephrine 100%
• Neuroprotective Agent 28%
• Transcription Factors 28%
• Neurotransmitter 14%
• Glial Cell Line-Derived Neurotrophic Factor 14%
• Parkinson's Disease 14%
• In Vivo 14%
• Brain-Derived Neurotrophic Factor 14%
• Multiple Sclerosis 14%
• Cyclic Adenosine Monophosphate 14%
• CREB 14%
• Gene Expression 14%
• In Vitro 14%
• Down Syndrome 14%
• Alzheimer's Disease 14%
• Posttraumatic Stress Disorder 14%
• Receptor 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Noradrenalin 100%
• Diseases 42%
• Neuroprotective Agent 28%
• Transcription Factors 28%
• Receptor 14%
• Brain Derived Neurotrophic Factor 14%
• Neurotransmitter 14%
• Glial Cell Line Derived Neurotrophic Factor 14%
• Alzheimer's Disease 14%
• Posttraumatic Stress Disorder 14%
• Parkinson's Disease 14%
• Multiple Sclerosis 14%
• Down Syndrome 14%